HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.
Fatty liver disease in obesity

Non-alcoholic fatty liver disease (NAFLD) is a common liver condition closely linked to obesity. In individuals with obesity, excess fat accumulates in the liver, leading to inflammation and potential scarring. Over time, NAFLD can progress to more severe conditions such as cirrhosis and liver failure. This condition is often associated with metabolic disorders like insulin resistance, high cholesterol, and hypertension. Weight management is critical in treating and preventing NAFLD, as losing even a small percentage of body weight can significantly reduce liver fat and inflammation. A combination of a low-calorie diet, regular exercise, and pharmacological treatments when necessary can help reduce fat accumulation in the liver and prevent further damage, improving liver function and overall health outcomes.

Committee Members
Speaker at World Obesity and Weight Management Congress 2026 - Russell Rising

Russell Rising

D & S Consulting Services Inc, United States
Speaker at World Obesity and Weight Management Congress 2026 - Robert Gabbay

Robert Gabbay

Harvard Medical School, United States
Speaker at World Obesity and Weight Management Congress 2026 - Hassan Massoud Heshmati

Hassan Massoud Heshmati

Endocrinology Metabolism Consulting, LLC, Hassan Heshmati and Valerie Shaw Endocrine Research, United States
Tags

Submit your abstract Today

Twitter XTwitter
Watsapp